Area of research
Pathology and Forensic Medicine · Public Health, Environmental and Occupational Health
Research interest
Research interests include Lymphoma Diagnosis and Treatment, Acute Lymphoblastic Leukemia research, Viral-associated cancers and disorders, and Chronic Lymphocytic Leukemia Research.
Significant Variability in the Identification and Reporting of Band Neutrophils by Participants Enrolled in the College of American Pathologists Proficiency Testing Program: Time for a Change
Successful Outcomes of Newly Diagnosed T Lymphoblastic Lymphoma: Results From Children’s Oncology Group AALL0434
<i>IRF4</i> translocation status in pediatric follicular and diffuse large B‐cell lymphoma patients enrolled in Children's Oncology Group trials
Overall survival of children and adolescents with mature B cell non‐Hodgkin lymphoma who had refractory or relapsed disease during or after treatment with <scp>FAB</scp>/<scp>LMB</scp> 96: A report from the <scp>FAB</scp>/<scp>LMB</scp> 96 study group
Excellent outcomes in children and adolescents with <scp>CNS</scp><sup>+</sup> Burkitt lymphoma or other mature B‐<scp>NHL</scp> using only intrathecal and systemic chemoimmunotherapy: results from <scp>FAB</scp>/<scp>LMB</scp>96 and <scp>COG ANHL</scp>01P1
Ibrutinib significantly inhibited Bruton’s tyrosine kinase (BTK) phosphorylation,<i>in-vitro</i> proliferation and enhanced overall survival in a preclinical Burkitt lymphoma (BL) model
Genetic evaluation of juvenile xanthogranuloma: genomic abnormalities are uncommon in solitary lesions, advanced cases may show more complexity
Genomic analysis of follicular dendritic cell sarcoma by molecular inversion probe array reveals tumor suppressor-driven biology
The effects of DLEU1 gene expression in Burkitt lymphoma (BL): potential mechanism of chemoimmunotherapy resistance in BL
Comparative genomic expression signatures of signal transduction pathways and targets in paediatric Burkitt lymphoma: a Children's Oncology Group report
Clinical utility of next‐generation sequencing in the diagnosis of hereditary haemolytic anaemias
Rare Pediatric Non-Hodgkin Lymphomas: A Report From Children's Oncology Group Study ANHL 04B1
Current status and future directions of T‐lymphoblastic lymphoma in children and adolescents
Prognostic Impact of Tumor Microenvironment in Diffuse Large B-Cell Lymphoma Uniformly Treated With R-CHOP Chemotherapy
Bone Marrow Synoptic Reporting for Hematologic Neoplasms: Guideline From the College of American Pathologists Pathology and Laboratory Quality Center
Revised International Pediatric Non-Hodgkin Lymphoma Staging System
Rituximab with chemotherapy in children and adolescents with central nervous system and/or bone marrow‐positive <scp>B</scp>urkitt lymphoma/leukaemia: a Children's Oncology Group Report
Advanced stage anaplastic large cell lymphoma in children and adolescents: Results of ANHL0131, a randomized phase III trial of APO versus a modified regimen with vinblastine: A report from the children's oncology group
Optimized immunohistochemical panel to differentiate myeloid sarcoma from blastic plasmacytoid dendritic cell neoplasm
microRNA expression profiling identifies molecular signatures associated with anaplastic large cell lymphoma
Disseminated lymphoblastic lymphoma in children and adolescents: results of the <scp>COG A</scp>5971 trial: a report from the <scp>C</scp>hildren's <scp>O</scp>ncology <scp>G</scp>roup
Rasburicase in the prevention of laboratory/clinical tumour lysis syndrome in children with advanced mature <scp>B</scp>‐<scp>NHL</scp>: a <scp>C</scp>hildren's <scp>O</scp>ncology <scp>G</scp>roup <scp>R</scp>eport
Rituximab pharmacokinetics in children and adolescents with <i>de novo</i> intermediate and advanced mature B‐cell lymphoma/leukaemia: a Children's Oncology Group report
The immunophenotype of <scp>T</scp> ‐lymphoblastic lymphoma in children and adolescents: a <scp>C</scp> hildren's <scp>O</scp> ncology <scp>G</scp> roup report
Outcome and pathologic classification of children and adolescents with mediastinal large B-cell lymphoma treated with FAB/LMB96 mature B-NHL therapy
Molecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic profiling
Outcome of newly diagnosed children and adolescents with localized lymphoblastic lymphoma treated on Children's Oncology Group trial A5971: A report from the Children's Oncology Group
<scp>TP</scp>53 pathway analysis in paediatric <scp>B</scp>urkitt lymphoma reveals increased <i><scp>MDM</scp>4</i> expression as the only <scp>TP</scp>53 pathway abnormality detected in a subset of cases